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Introduction: Long lasting anesthesia of the soft tissue beyond the dental treatment affects patients in daily
routine. Therefore a sophisticated local anesthesia is needed. The purpose of this study was an evaluation of the
clinical use of epinephrine-free local anesthetic solutions in routine short-time dental treatments.
Materials and methods: In a prospective, single-blind, non-randomized and controlled clinical trial, 31 patients
(16 male, 15 female patients) undergoing short-time dental treatment under local anesthesia (plain solutions of
articaine 4% and mepivacaine 3%) in area of maxillary canine were tested with quantitative sensory testing QST.
Paired-Wilcoxon-testing (signed-rank-test) and Mc Nemar tests have been used for statistical results.
Results: Significant differences in all tested parameters to the time of measurements were found. Mepivacaine
showed a significantly stronger impact for the whole period of measurement (128 min) on thermal and mechanical
test parameters and to the associated nerve fibers.
Conclusion: Plain articaine shows a faster onset of action associated with a shorter time of activity in comparison to
plain mepivacaine. In addition to this articaine shows a significant low-graded effect on the tested nerve-fibers and
therefore a least affected anesthesia to the patient. The clinical use of an epinephrine-free anesthetic solution can be
stated as possible option in short dental routine treatments to the frequently used vasoconstrictor containing local
anesthetics. Patients may benefit from shorter numbness.
Keywords: Articaine, Mepivacaine, Local anesthesia, Maxillary infiltration, Trigeminal region, Epinephrine-freeIntroduction
In dental treatment, the management of pain is an im-
portant factor for patient comfort and a critical element
of patient care [1,2]. A huge amount of local anesthetic
agents are used nowadays, but only a few of these avail-
able agents have been exposed to be more beneficial in
dental routine. These few compounds, which mostly
contain a vasoconstrictor e.g. epinephrine, are widely
used [3]. The clinical benefit of local anesthetics com-
bined with vasoconstrictors is obvious: local ischemia is
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less otherwise stated.which extends the duration activity and reduces the sys-
temic toxicity of the anesthetic agent [4,5].
However, there are also clinical situations, which do
not allow the use of agents containing vasoconstrictors,
particularly epinephrine. Clinical findings and contraindi-
cation in anamnesis are e.g. hypertension, hyperthyreosis,
diabetes mellitus and all advice of vasoconstrictions [6-11].
In order to avoid systemic adverse reactions, local
anesthetic solutions should always contain the minimum
concentration of epinephrine [4]. It is very important for
the clinician to be acquainted with the characteristics of
the agent. Especially pharmacological action, toxicity and
maximal dose are important parameters to know.
In addition attention has to be payed to the onset, the
depth of anesthesia and the duration of activity related
to the planned dental procedure. Unfortunately the
compounds, which are commonly used and contain aed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribu-
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routine nonsurgical short-time dental treatments. There
is a discrepancy between the time for dental procedures
and the time of agent’s activity, especially on patient’s
soft tissue [4]. Several studies have proved that soft tis-
sue anesthesia can last for 3 – 4 hours beyond the treat-
ment when an agent with vasoconstrictor was used
[12,13]. In particular the long-lasting anesthesia of soft
tissue, causing unpleasant numbness beyond the dental
treatment, affects the patient in daily routine. Eminently
because of this negative effect on patient’s comfort, local
anesthesia has to be justified for routine short-time den-
tal treatments.
A situation-related compound, which approaches the
possibility of a safe and adequate dental care and the
need of the patient, meaning a least affecting anesthesia,
has to be chosen [4,14]. Studies have confirmed that
plain solutions of local anesthesia provide an alternative
option to the commonly used compounds [14]. Al-
though a variety of plain local anesthetic solutions are
available, they are rarely used in daily routine. The plain
solutions Mepivacaine shows the typical structure of an
amino-amide local anesthetic and was object of different
studies [15]. In contrast to other local anesthetics of the
amino-amid type, plain mepivacaine shows vasoconstrictor-
properties at its disposal [15,16].
Articaine is also a local anesthetic of an amide type.
But since it possesses vasodilatation-properties [16], it is
mostly used in association with a vasoconstrictor increas-
ing the local anesthetic efficacy. The characteristic prop-
erty of articaine is its chemical structure: a thiophene-ring
in addition to an ester linkage. This chemical structure
represents an exception in the line of local anesthetics in
clinical use [1]. Several studies have exposed that articaine
is the local anesthetic agent with the best properties of dif-
fusion within soft and hard tissue [4].
In order to test the effect of soft tissue-anesthesia and
in particular the effect of the compound being used on
sensory modalities of large and small fibers (Aβ-, C- and
Aδ- fibers), a reliable noninvasive psychophysical test-
method can be performed; the quantitative sensory testing
(QST). This QST procedure has become an integrable
diagnostic tool in clinical routine with a standardized
battery of thermal and mechanical parameters [17,18].
It has already been used successfully in the trigeminal
region of face [17-21]. In the present study QST was
adapted to the hairy skin of the infraorbital region (V2)
during small dental interventions in maxillary premolares.
The aim of the current study is to elevate the clinical
use of vasoconstrictor-free local anesthetics in routine
short-time dental treatments and especially to discover
the effect of the local anesthetic agents (articaine/
mepivacaine) on sensory modalities of large and small
fibers (Aβ-, C- and Aδ- fibers) and the differences ofthe resulting soft-tissue anesthesia. The purpose is to
discover a situation-justifying agent, which can be used
by the clinician for routine short-time dental treatments
and also improves the situation of the patient due to the
limited duration of soft-tissue anesthesia.
Materials and methods
Patients
Thirty-one patients (15 female, male 16) covering an age
between 20 and 40 years (27.4 ± 4.0 years, mean ± SD) in
need of small nonsurgical dental treatment in region of
maxillary premolares were included in this prospective,
controlled non-randomized, single blind study. Only
patients, who fulfilled the inclusion criteria and none
of the exclusion criteria, were tested.
The inclusion criteria involved the necessity of a dental
filling therapy in maxillary premolar region, filling-free
maxillary canines, the wish of the patient and the medical
indication for a dental local anesthesia in the region of the
dental treatment and furthermore the age of the patients
(20 – 40 years). The exclusion criteria were all kinds of
cardiovascular-, metabolic-, CNS-, immune system- dis-
ease; furthermore coagulopathy, circulatory disorder, re-
cent operations, contagious diseases, sulfite sensitivity
or allergy to any part of the solution, psychiatric illness,
drug consumption and pregnancy. All patients have
been without any medication for 48 hours.
All participants gave their informed consent prior to
the inclusion in this study according to the 1964 declar-
ation of Helsinki. The study took place at the department
of conservative dentistry, periodontology and preventive
dentistry of RWTH University Aachen. The protocol
passed the local ethics committee (number of the accept-
ance by the ethic committee EK 076/11).
Thermal and mechanical detection and pain thresh-
olds were determined by the quantitative sensory testing
protocol (QST) [17,18,22]. In several studies it was rec-
ommended to reduce the originally QST protocol of 13
parameters to less parameters without affecting the in-
formative value of the measurement in order to ensure
an integration into clinical practice. With thermal and
mechanical stimuli of QST it is possible to show distinct
neuroanatomic pathways with Aβ, Aδ, and C fiber popu-
lations [21,23,24].
Because of the limited time of clinical routine it was
necessary to design a test-protocol obtaining the sensory
profiles within dental treatment. Therefore in the
present study 7 of the 13 possible test parameters of
QST were included into the test protocol; containing
CDT, cold detection threshold; WDT, warm detection
threshold; CPT, cold pain threshold; HPT, heat pain
threshold; MDT, mechanical detection threshold; MPT,
mechanical pain threshold and VDT, vibration detection
threshold. In addition to that the pulp sensory of the
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test period by using a cold test, which seeks a response
to the thermal stimulus (Figure 1).
Clinical examination- treatment protocol
At the beginning of every test period a control test was
implemented in order to demonstrate the test method to
the patient and to collect normative data. For realizing a
painless small dental treatment (fissure-filling-therapy in
premolares on both sides of maxilla) a maxillary local in-
filtration anesthesia in canine region was performed. For
that, plain solutions of articaine 4% (Ultracain D®,
Sanofi-Aventis, Paris, France) and mepivacaine 3% (Mea-
verin®, Actavis, New Jersey, USA) were applied. The local
anesthetics were given to all patients, alternately on the
right and left side of maxilla; in conclusion every agent
was nearly administered equal times on every side.
Thereby an amount of 1.00 ml solution was given in
30 sec per dental syringe (Uniject k®, Fa. Sanofi-Aventis,
Paris, France) always performed by the same dentist. Im-
mediately after the injection the first test of the test-
interval was performed; each test, containing QST and
the test of pulp sensibility, took 9 min. During the five-
minute breaks between every single test-interval, the
dental treatment was performed. Patients were lying on
a dental chair and kept their eyes closed throughout the
QST procedure. Half of the group was tested on the
right side first, the other half on the left side. All tests
were performed by the same trained examiner.
Quantitative sensory testing
The test protocol containing thermal and mechanical
detection, as well as pain thresholds, was always applied
in the same order. Thereby the patients were tested ther-
mal before mechanical testing occured.
All thermal stimuli were assigned by a special
computer-controlled peltier type thermode with a stimu-
lation area of 16 × 16 mm2 (TSA-II, Medoc Ltd., Israel).
Starting at a temperature-baseline of 32°C, the temperature
of the thermode decreased or increased by 1°C/sec to de-
termine thermal detection and pain thresholds (CDT,
WDT, CPT, and HPT). The patients were asked to press aFigure 1 Stimulation protocol.computer mouse button as soon as they observed the cor-
responding cold, warm, cold pain, or heat pain sensation.
After receiving measurement results, the temperature of
the thermode returned to baseline-temperature for each
thermal threshold. In order to protect the patient’s skin,
the range of stimulation temperatures was controlled
between 0 – 50°C. The test-procedure for cold and
warm detection thresholds (CDT, WDT) was performed
firstly. Afterwards cold pain- and heat pain thresholds
(CPT, HPT) were determined.
The mechanical test procedure contained the thresh-
olds for MDT, MPT and VDT.
MDT was rated with modified von Frey filaments fea-
turing forces of 0.08, 0.2, 0.4, 0.7, 1.6, 4, 6, 10, 14, 20, 40,
60, 80, 100, 150, 260, 600, 1.000, 1.800, 3.000 mN
(Touch-Test Sensory Evaluators; North Coast Medical,
Morgan Hill, CA, USA).
For performing the measurement of MPT, custom-
made weighted pinprick stimulators with forces of 8, 16,
32, 64, 128, and 256 mN and a contact area of ca.
0.2 mm diameter were applied to hairy skin of the infra-
orbital region.
MDT and MPT were set by the method of limits start-
ing with a clearly noticeable filament of 16 mN and a
non-painful pinprick stimulator of 8 mN.
Both thresholds were defined as the geometric mean
of 5 series of descending and ascending stimulus inten-
sities [25,26].
The vibration stimuli were applied by a 64-Hz Rydel-
Seifer tuning fork (OF033N; Aesculap, Tuttlingen,
Germany) that was placed over the maxilla (infraorbital
nerve area). Threshold measurement was performed 3
times starting with maximum vibration amplitude. As
soon as the subject indicated disappearance of vibratory
sensation, the threshold was read on a scale ranging from
0/8 to 8/8 (steps of 1/8). VDT was defined as the arith-
metic mean of 3 runs [25,26].
Statistical analysis
All statistics were done in an explorative manner; no ad-
justment of significance level for multiple testing was
performed. The function of statistic was to investigate
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at testing time; furthermore to discover the differences
between the measurement of control tests and continu-
ing measurement tests. For all QST parameters differ-
ences between the agents were performed using the
Wilcoxon-signed rank test. Testing the pulp sensibility
the Mc Nemar Test was performed. Significance level
was accepted at p < 0.05. Statistical analysis was done
with SigmaStat 11.0 (SPSS Inc., USA) and SAS (SAS In-
stitute Inc., USA).
Results
Altogether, thirty-one patients, sixteen male and fifteen
female, with a mean age of 27.4 ± 4,0 years (mean ± SD),
a mean size of 173.6 ± 6.3 cm (mean ± SD) and a mean
weight of 69,3 ± 10,6 kg (mean ± SD) could be included.
Thermal testing
The effect of both anesthetic agents showed significant
differences at each time of measurement for CDT as well
as for WDT (Table 1, Figure 2). Equivalent amounts of
the two local anesthetics exerted a different effect on the
intense temperature-detection thresholds. Mepivacaine
showed a stronger influence (p < 0.05) on the temperature
sensitivity across all points of measuring, as well as higher
detection thresholds (p < 0.05) in CDT and WDT than
articaine. For both, CDT (p < 0.001) and WDT (p < 0.01),
the values of control measurement were not achieved
until the end of measurement progress. Until the last
point of measurement (128th minute) a significant differ-
ence between the control measurement and the course
measurements existed. Moreover, significant differences in
anesthesia profiles occured in CPT as well as in HPT. By
comparing the analysis of the control value and the course
measurements an end of significant differences for cold
pain threshold (CPT) was reached within the measure-
ment period in both preparations. Articaine reached the
value of control measurement earlier (t = 72 min, p > 0.05)
than mepivacaine (t = 100 min, p > 0.05). Only at heat pain
threshold (HPT) no significant differences were registered
for articaine from the point of mensuration (t = 100 min,
p > 0.05) to the received value of the control measure-
ment. Even CPT and HPT showed that mepivacaine had a
greater effect on thermal pain thresholds (p < 0.05) and
maintained this throughout the measuring time.
Mechanical testing
For MDT as well as MPT, significant differences between
the measured sensitivity thresholds were recorded at
each time of testing (Table 2, Figure 3). At the tactile de-
tection threshold MDT the measurement values of the
control measurement were not reached in mepivacain
over the entire measurement time course (p < 0.05). At
the local anesthetic articaine a comparison with thecourse of measurements shows that the biggest interfer-
ence of MDT was directly after the injection. In follow-
ing development sensitivity of the skin returned steadily.
Up to 100th Minute, a significant discrepancy between
the control measurement and course measurements
were demonstrated (p < 0.05). From the 114th minute no
significant difference with the control measurement con-
sisted (p > 0.05).
On MPT, articaine abolished the difference to the con-
trol test result from the point of the 72 min (p > 0.05).
The significant difference between control measurement
and results of process of mepivacaine existed until the
end of measurement (p < 0.05). Mepivacaine had a stron-
ger influence (p > 0.05) over the entire time of measure-
ment on MDT as well as on MPT; in direct comparison
to articaine, relevant thresholds were increased signifi-
cantly during the whole period of time. Almost over the
entire measurement in VDT, mepivacaine had a stronger
effect than articaine, whereas only two measurements
showed a significant discrepancy between the two agents.
Again, both pharmaceutical values of the control measure-
ment were achieved for the measurement progress,
whereas that proceeded faster for articaine (t = 58 min,
p > 0.05) than for mepivacaine (t = 114 min, p > 0.05;
Figure 3).
Testing the pulp sensibility
The measurements of testing pulp sensitivity of the
anesthetized tooth showed significant differences between
the two local anesthetics at three points of measurement.
The success rate for maxillary buccal infiltration in canine
area to produce pulpal anesthesia using articaine was
74.19%, while the success rate was 90.32% using mepiva-
caine solution. By using mepivacaine it was possible to
anesthetize more patients at the treated teeth region for a
longer time. For both agents returning to baseline pulp
sensibility was obtained within the testing period, while
this point was reached earlier using articaine as agent
(t = 44 min, p > 0.05) than using mepivacaine as agent
(t = 58 min, p > 0.05; Figure 4).
The results of duration of pulp sensitivity testing
showed a similar course. A period in which a positive
sensitivity testing was considerably increased was 16 to
58 minutes for mepivacaine. At this period the two
drugs showed differences, whereas the minutes 30 and
44 were significant (p < 0.05). In both preparations no
significant differences between the measurement of con-
trol and the course measurements, starting at 86th mi-
nute, were observed (p > 0.05).
Discussion
Method and external parameter
In this prospective study, a non-randomized controlled
clinical trial, 31 patients (16 male, 15 female patients)
Table 1 Measurement results of the QST thermal testing (CDT, CPT, WDT, HPT)
CDT CPT
Articaine 4% Mepivacaine 3% Articaine 4% Mepivacaine 3%
Time of
measurement [min]
median [°C] p-value control
vs. course




median [°C] p-value control
vs. course




Control- measurement 29,90 - 30,30 - - 14,30 - 15,50 - -
2 7,90 <0,001 0,00 <0,001 0,346 0,00 <0,001 0,00 <0,001 0,85
16 16,60 <0,001 0,00 <0,001 0,036 0,00 <0,001 0,00 <0,001 0,129
30 25,20 <0,001 1,10 <0,001 <0,001 9,60 0,005 0,00 <0,001 <0,001
44 26,80 <0,001 14,50 <0,001 <0,001 12,40 0,070 0,00 <0,001 0,022
58 26,10 <0,001 23,30 <0,001 0,004 10,50 0,029 0,00 <0,001 0,047
72 26,80 <0,001 26,30 <0,001 0,018 13,70 0,139 3,10 <0,001 0,02
86 28,00 0,003 27,50 <0,001 0,034 15,00 0,631 10,80 0,006 0,013
100 28,20 0,012 27,30 <0,001 0,011 15,50 0,822 12,50 0,094 0,011
114 28,30 0,004 28,10 <0,001 0,245 16,30 0,524 14,30 0,411 0,053















Table 1 Measurement results of the QST thermal testing (CDT, CPT, WDT, HPT) (Continued)
WDT HPT
Articaine 4% Mepivacaine 3% Articaine 4% Mepivacaine 3%
Time of
measurement [min]
Median [°C] p-value control
vs. course




Median [°C] p-value control
vs. course




Control- measurement 34,30 - 34,30 - - 42,40 - 43,50 - -
2 50,00 <0,001 50,00 <0,001 0,042 50,00 <0,001 50,00 <0,001 0,156
16 48,60 <0,001 50,00 <0,001 0,021 50,00 <0,001 50,00 <0,001 0,074
30 41,00 <0,001 50,00 <0,001 <0,001 48,30 <0,001 50,00 <0,001 <0,001
44 38,70 <0,001 50,00 <0,001 <0,001 48,00 <0,001 50,00 <0,001 <0,001
58 37,20 <0,001 46,20 <0,001 <0,001 47,30 <0,001 50,00 <0,001 0,007
72 36,50 <0,001 42,80 <0,001 <0,001 45,50 <0,001 49,60 <0,001 0,006
86 36,20 <0,001 40,10 <0,001 0,002 44,30 0,007 47,30 <0,001 0,008
100 36,50 <0,001 37,70 <0,001 0,016 45,00 0,052 47,50 0,002 0,008
114 35,60 0,003 36,80 <0,001 0,041 42,80 0,376 47,40 <0,001 <0,001















Figure 2 (See legend on next page.)
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Figure 2 Presentation of the results of the thermal QST parameters (A: CDT Articain, CDT Mepivacain; B: CPT Articain, CPT Mepivacain;
C: WDT Articain, WDT Mepivacain D: HPT Articain, HPT Mepivacain) and the results of the statistical analysis for the individual
measurement points (inclusive standard deviation). Significant differences are indicated by asterisks (paired Wilcoxon test: p ***≤ 0.001;
** p≤ 0.01, p≤ 0.05 *, ns = not significant). The upper asterisks indicate significant differences between the measured values of articaine and
mepivacaine to the respective measurement time. The lower asterisks indicate significant differences between the control measurement value
and the running values of each anesthetic. Median value (solid line) and mean value (dotted line) are shown within the boxplots.
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dental treatment under local anesthesia in area of maxil-
lary canine.
As previous studies proved that a difference in the per-
ception of sensitive stimuli between healthy men and
women does exist in this study, attention was paid to a
homogeneous distribution of gender in order to avoid
prejudicing the results. Furthermore, the age lowers the
pain threshold (higher sensitivity) and leads to a slightly
different reception of hot and cold stimuli [20,24,27,28].
In this study, the age of patients was limited in order to
avoid any influences on the measurement results.
In previous studies QST was used successfully in the
infraorbital region as detection method [20,24]. This
study discovered the investigation area for the examin-
ation as a suitable method. This is attributable to the
fact that on the one hand the region of canine represents
an extremely sensitive area of innervation (N.trigeminus,
N.infraorbitalis V2) and on the other hand the require-
ment of reproducibility is satisfied since the canine-
region is used, despite individual anatomical differences,
as a reference point for the repeated application of the
measuring instruments. A difference in perception be-
tween the left and right sides of the examined QST pa-
rameters could not be determined [24,29].
In this study attention was particularly paid to the side
distribution using local anesthetics. Both preparations
were used on both sides for equal times. Thereby side
distribution did not have an impact on the results.
In dentistry, choosing the right local anesthetics is of
huge importance, the aspects of biocompatibility, toler-
ability and allergic potential should be considered [25,30].
The effect of local anesthetics on sensitivity can be evalu-
ated in different ways. Commonly used methods examine
the sensitivity of the anesthetized tooth, i.e. by checking
the sensibility of the nerve fibers within the pulp. In order
to check them, physical methods which involve thermal-
(cold or heat application), electrical- and electro-optical
measurement are used [26]. But those methods do not
offer a review of the sensitivity of soft tissue, since it is also
numbed by the used agent. Nevertheless the anesthesia of
soft tissue, which most often affects the patient beyond
the dental treatment, is an inevitable side effect of local
anesthesia in dentistry and should be limited temporally, if
possible. Especially for minor procedures, such as a
routine-small-non surgical dental treatment, a discrepancybetween the time of dental treatment implementation and
the effect of anesthesia within the treated area as well as
on the soft tissue does exist. Within currently available
methods to study the function of sensory Aδ-, Aß- and C-
fibers, QST is a reliable and repeatable method [20,24,31].
A comparison between different local anesthetics of equal
amounts is restricted, since different anesthetic-agents have
various relative efficacies and various intrinsic activities.
Local anesthetics with an approximately similar relative
efficacy and intrinsic activity, but a different molecular
weight, can only be compared theoretically in equimolar
solutions. Studies working with equimolar solutions are
only partially applied in practical clinical use. The applic-
ability of data obtained in this study has priority for dental
daily routine. In the present study, always the same vol-
ume (1.00 ml) of the different anesthetic-agent was ap-
plied, despite the fact that different doses were applied to
each side. The used volume was taken to ensure both: first
of all that local anesthesia of tooth for the short dental
procedure was adequate and furthermore that the investi-
gation of the anesthetic effect on soft tissue performing
QST was in a realizing range (128 minutes) for the patient.
Action of local anesthetics on pulpal sensitivity/effect of
the local anesthetic to the QST parameters and their
associated nerve fibers
The investigation of the effect of anesthesia on pulp
sensibility showed that there are significant differences
between the compared preparations. Mepivacaine is the
stronger preparation in the applied volume. It has both,
a stronger effect in terms of absolute number of negative
samples than articaine, as well as the time until positive
samples of sensitivity are measured. Articaine, however,
shows a faster onset of action associated with a short
duration of action.
Articaine has a higher number of negative samples of
detectable sensitivity immediately after the application.
This observation is also consistent with results of other
studies. Because of a good bone- and soft tissue penetra-
tion of the active agent articaine, a possible reason for
the rapid onset of action can be proven in different stud-
ies [32-34]. Mepivacaine reaches the maximum effect at
a later point of time (t = 16 min).
In vitro studies confirm a consistent finding that arti-
caine seems to be superior in the anesthetic efficacy. In
an in vitro study Potocnik et al. were able to show that
Table 2 Measurement results of the QST mechanical testing (MDT, MPT, VDT)
MDT MPT VDT













































0,06 - 0,06 - - 5,66 - 5,66 - - 7,00 - 7,00 - -
2 122,47 <0,001 4242,64 <0,001 0,004 362,04 <0,001 362,04 <0,001 0,037 5,00 <0,001 5,00 <0,001 0,625
16 69,28 <0,001 2323,79 <0,001 <0,001 362,04 <0,001 362,04 <0,001 0,02 6,00 <0,001 5,00 <0,001 0,041
30 7,75 <0,001 197,48 <0,001 <0,001 90,51 <0,001 362,04 <0,001 <0,001 6,00 0,002 5,00 <0,001 <0,001
44 0,53 <0,001 28,28 <0,001 <0,001 22,63 <0,001 181,02 <0,001 <0,001 6,00 0,008 6,00 <0,001 0,104
58 0,53 <0,001 11,83 <0,001 <0,001 11,31 <0,001 90,51 <0,001 <0,001 6,00 0,063 6,00 <0,001 0,054
72 0,13 <0,001 1,06 <0,001 <0,001 5,66 0,016 22,63 <0,001 <0,001 7,00 0,25 6,00 0,078 0,129
86 0,06 <0,001 0,28 <0,001 <0,001 5,66 0,188 22,63 <0,001 <0,001 6,00 0,375 6,00 0,016 0,098
100 0,06 0,009 0,13 <0,001 <0,001 5,66 1 11,31 <0,001 <0,001 7,00 0,25 6,00 0,008 0,055
114 0,06 0,055 0,13 <0,001 <0,001 5,66 1 5,66 0,01 0,005 7,00 0,109 6,00 0,125 0,844















Figure 3 Presentation of the results of themechanical QST parameters (A: MDT Articain, MDTMepivacain; B: MPT Articain, MPTMepivacain;
C: VDT Articain, VDTMepivacain) and the results of the statistical analysis for the individualmeasurement points (inclusive standarddeviation).
Control measurement and anesthesia course of the two local anesthetics in direct comparison. Significant differences are indicated by asterisks (paired
Wilcoxon test: p ***≤ 0.001; ** p≤ 0.01, p≤ 0.05 *, ns = not significant). The upper asterisks indicate significant differences between the measured
values of articaine and mepivacaine to the respective measurement time. The lower asterisks indicate significant differences between the control
measurement value and the running values of each anesthetic. Median value (solid line) and mean value (dotted line) are shown within the boxplots.
Said Yekta-Michael et al. Head & Face Medicine  (2015) 11:2 Page 10 of 13at sural nerve of a rat articaine 4% anesthetic solution
was more effective than a lidocaine 4% or mepivacaine
3% solution [35]. This result has also been demonstrated
in other in vitro studies on isolated nerves of frogs and
rats [36].
In a comparative clinical trial Cowan could show that
in a dental infiltration anesthesia with equal volumes
(1.00 ml) of anesthetic agents the anesthetic effect of
articaine without an added vasoconstrictor is less than
the anesthetic effect of lidocaine 2% and mepivacaine 3%
[15]. A similar result was also obtained by Winther and
Nathalang in a comparative study. They discovered that
the epinephrine-free solution could cause lack of ad-
equate clinical analgesia in both, 2% and in 4% concen-
tration, in contrast to epinephrine-containing articainesolutions [37]. In a comparison of 1% solutions of both
local anesthetics Sommer et al. showed that mepivacaine
had almost the doubled action time as articaine [38]. A
possible reason may be the low but existing vasocon-
strictor effect of mepivacaine and the pronounced vaso-
dilatory effect of articaine. These substance properties
play only a minor role in the in vitro model of the iso-
lated nerve, whereas they are quite detectable in clinical
use because of the vascularized tissue [1]. In contrast to
that, Rahn et al. demonstrated that a 2% articaine-
epinephrine-free solution compared to standard articaine
(4% articaine with epinephrine solution of 1/200.000) can
be perfectly used in clinical routine and has even be
proven in surgical intervention. This performance was
also confirmed by Kämmerer et al. who successfully used
Figure 4 Representation of the relative frequency of positive samples to the sensitivity of the individual measuring time points for
both local anesthetics in direct comparison.
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tion in the mandible [14,39]. A comparison of dental
anesthetic success of local anesthetics between this study
and other studies shows that the observed anesthesia suc-
cess in this study agrees with the values obtained in other
studies. The anesthesia success for mepivacaine is assessed
as high (t = 16 min, anesthesia success 90.32%) and for
articaine as moderate (t = 2 min, anesthesia success
74.19%). Moore et al. were able to achieve a comparative
success with articaine 4% anesthesia without epinephrine
in a maxillary infiltration anesthesia (1.00 ml) of 75.8%.
This almost agrees with the results of this study [40-43].
The study demonstrates that the applied amount of
1.00 ml of the anesthetic agent articaine is sufficiently
high to achieve adequate success of anesthesia during
small dental procedures.
The results of the QST parameters permit conclusions
of certain nerve fibers [18,31]. Differences of the two
preparations are obvious.
The two preparations show significant differences of
the individual measuring times to each other and also of
the control value compared to the values of each con-
tinuing measurements.
No significant difference between the control values
and the measurement values of articaine in five of seven
tests could be observed. This was only achieved at two
of seven test parameters by mepivacaine. However, a dif-
ferentiated end of the blockade and the regeneration of
individual nerve fibers from the active ingredient of the
local anesthetic are not evident. Accordingly, the sensitivityto the local anesthetic does not only depend on the diam-
eter of the individual nerve fibers, but notably on the
choice of the active substance and its physicochemical
properties [44]. In opposite to the conventional amide an-
esthetics mepivacaine, which is only degraded in the liver,
articaine, being metabolized in the liver and in plasma by
Pseudocholinesterasen, shows a short interference of the
thresholds which were measured. Furthermore, plain arti-
caine has its strongest effect just after the injection at the
first measurement point (based on the sensitivity of the
tooth anesthetized). Whereas this can firstly be registered
a measurement point later in the case of mepivacaine.
Thus, the excellent tissue penetration and rapid onset of
action can be confirmed for the active agent articaine,
which is awarded in various studies. Both factors are based
on the physicochemical properties, in particular increased
by the thiophene lipophilicity. This allows a more efficient
diffusion of articaine through soft tissue than other local
anesthetics [32-34].
Aβ- fibers (MDT, VDT)
The study of myelinated Aβ-fibers took place via QST
parameters MDT and VDT. This demonstrates that
there are significant differences at all measuring times
between the two preparations at MDT. The active agent
mepivacaine showed a stronger influence on MDT as
articaine at all measuring times. A significant difference
between the control value and the value of the course of
the active agent mepivacaine was detectable on the en-
tire range of measurement. In contrast to that, articaine
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measurement time (114 minutes). In various studies,
which were already carried out on the face, MDT pre-
sented to be particularly sensitive test parameters [18].
The local anesthetic effect on these test parameters
might be the reason for the long time influence.
The VDT test parameters show significant differences
of the two preparations concerning the measuring times
of 16 and 30 minutes. Again, mepivacaine was more ef-
fective than articaine.
The comparison between the control values and the
progress values showed no significant difference at the
end of measurement for both active substances, al-
though the end of significant differences was reached
earlier by articaine than by mepivacaine. The results
show that the myelinated Aβ-fibers, which are associated
with the test parameters, recover very fast from the local
anesthetic action. This agrees with previous studies
[45,46]. Especially articaine seems to affect Aβ-fibers less
than mepivacaine. However, it should be noted that
there can be a transmission of the vibration to the max-
illary bone protrusion [24]. This may lead to stimulation
of unanesthetized areas, a distortion of the measured
values and that VDT loses informative value compared
with MDT.Aδ- fibers (CDT, MPT, HPT)
The test parameters associated with the Aδ-fiber activity
show at almost all points of time significant differences
between the two preparations. Thereby mepivacaine has
a stronger effect on the test parameters than articaine.
The test parameters HPT and MPT do not show sig-
nificant differences between the progress values and the
control value for articaine within the study period of
128 minutes at the end of the measurements.
The results suggest that articaine has less influence on
Aδ-fiber activity than mepivacaine. Also the regeneration
of nerve fibers from the local anesthetic effect of arti-
caine is faster than the regeneration from the effect of
mepivacaine.C-fibers (WDT, CPT, HPT)
The test parameters associated with the C-fiber activity
showed at almost all points of measurement a significantly
stronger effect of mepivacaine compared to articaine. Dur-
ing the test a significant difference of both agents remains
at WDT parameters until the end of the measurement
period. However, a stronger influence of the test param-
eter was recorded for mepivacaine. Surprisingly, it appears
that at CPT the significant difference between the value of
measurements and the control value was canceled for
both agents. This occured faster in the case of articaine
than in the case of mepivacaine.As far as HPT is considered, only articaine achieved
the end of significant difference during the measure-
ment, whereas mepivacaine still showed significant dis-
crepancy during the measurement range to the end of
measurement.
Conclusion
The aim of the study was to investigate the analgesic ef-
fect of tooth as well as the anesthetic numbing effect of
soft tissue which is caused by local anesthetics as 4%
articaine and 3% mepivacaine which do not contain a
vasoconstrictor. The results of this study show that
mepivacaine causes a longer analgesia to the anesthe-
tized tooth and has a stronger influence on the investi-
gated thermal and mechanical test parameters at all
measurement points of time. Plain articaine 4% shows
an earlier onset of action associated with a shorter time
of activity in comparison to plain mepivacaine 3%. This
can result in more frequent injections of the local
anesthetic agent, if articaine is used. In addition to this
articaine shows a significant low-graded effect on the
tested nerve-fibers and therefore a least affected
anesthesia to the patient. Plain articaine 4% is very close
to the demands of a differentiated anesthesia. The clin-
ical use of an epinephrine-free anesthetic solution can
be stated as possible option in short dental routine treat-
ments to the frequently used vasoconstrictor containing
local anesthetics.
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